https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-06-30 / Cell. Immunol. 2006 Feb;239(2):144-50
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-06-30 / Cell. Immunol. 2006 Feb;239(2):144-502006-06-30 00:00:002019-02-15 09:11:48Induction of alpha-fetoprotein-specific CD4- and CD8-mediated T-cell response using RNA-transfected dendritic cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-06-01 / Cell. Mol. Immunol. 2006 Jun;3(3):197-203
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-06-01 / Cell. Mol. Immunol. 2006 Jun;3(3):197-2032006-06-01 00:00:002019-02-15 09:03:06Dendritic cell as therapeutic vaccines against tumors and its role in therapy for hepatocellular carcinoma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-05-01 / Clin. Cancer Res. 2006 May;12(9):2817-25
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-05-01 / Clin. Cancer Res. 2006 May;12(9):2817-252006-05-01 00:00:002006-05-01 00:00:00A phase I/II trial testing immunization of hepatocellular carcinoma patients with dendritic cells pulsed with four alpha-fetoprotein peptides
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-02-10 / Cell. Immunol. 2005 Nov;238(1):61-6
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-02-10 / Cell. Immunol. 2005 Nov;238(1):61-62006-02-10 00:00:002019-02-15 09:03:07Specific antihepatocellular carcinoma T cells generated by dendritic cells pulsed with hepatocellular carcinoma cell line HepG2 total RNA
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-01-01 / Cytotherapy 2006;8(6):580-8
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-01-01 / Cytotherapy 2006;8(6):580-82006-01-01 00:00:002019-02-15 09:03:05Comparative analysis of DC fused with tumor cells or transfected with tumor total RNA as potential cancer vaccines against hepatocellular carcinoma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2005-11-14 / World J. Gastroenterol. 2005 Nov;11(42):6571-6
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2005-11-14 / World J. Gastroenterol. 2005 Nov;11(42):6571-62005-11-14 00:00:002019-02-15 09:11:49Immunological treatment of liver tumors
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2005-10-01 / Oncol. Rep. 2005 Oct;14(4):969-73
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2005-10-01 / Oncol. Rep. 2005 Oct;14(4):969-732005-10-01 00:00:002019-02-15 09:03:11Administration of dendritic cells in cancer nodules in hepatocellular carcinoma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2005-09-28 / World J. Gastroenterol. 2005 Sep;11(36):5614-20
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2005-09-28 / World J. Gastroenterol. 2005 Sep;11(36):5614-202005-09-28 00:00:002019-02-15 09:03:09Dendritic cells pulsed with hsp70-peptide complexes derived from human hepatocellular carcinoma induce specific anti-tumor immune responses
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2005-09-01 / Hepatogastroenterology 2005 Sep-Oct;52(65):1502-6
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2005-09-01 / Hepatogastroenterology 2005 Sep-Oct;52(65):1502-62005-09-01 00:00:002019-02-15 09:03:11Immune-related effects of local hyperthermia in patients with primary liver cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2005-09-01 / J. Immunother. 2005 Sep-Oct;28(5):496-504
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2005-09-01 / J. Immunother. 2005 Sep-Oct;28(5):496-5042005-09-01 00:00:002020-01-08 10:10:20Vaccination of advanced hepatocellular carcinoma patients with tumor lysate-pulsed dendritic cells: a clinical trial
